SURGE Therapeutics Stock

www.surgetx.com/Healthcare / BioTech & PharmaFounded: 2016

SURGE Therapeutics, founded in 2016, is a healthcare company that seeks to dramatically improve cancer patient survival by disrupting how cancer immunotherapy is deployed. The company provides an injectable, biodegradable hydrogel that aims to allow for the prolonged, localized release of most cancer immunotherapy by focusing the dose at the right place and right time. SURGE Therapeutics is headquartered in Cambridge, Massachusetts.

Register for Details

For more details on financing and valuation for SURGE Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for SURGE Therapeutics.

Register Today

Team

Management Team

Michael Goldberg Ph.D
Founder, Chief Executive Officer & President
Charles Carignan MD
Chief Experience Officer

Board Members

Oliver Keown MD
Intuitive Ventures

Other companies like SURGE Therapeutics in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.74B

News Highlights

This Startup Just Raised $32 Million To Keep Cancers From Recurring After Surgery
On Wednesday, the company announced it has raised a $32 million series B round. The deal brings its total venture investments to $60 million. The company plans to use the new investment to continue development of its immunotherapy and to advance clinical trials for it.
Updated on: Oct 3, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.